Cargando…

Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial

Detalles Bibliográficos
Autores principales: Clark, Marie, Wang, Fang, Bodet, Nancy D., Kim, Brian S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178825/
https://www.ncbi.nlm.nih.gov/pubmed/32337373
http://dx.doi.org/10.1002/hsr2.154
_version_ 1783525545018916864
author Clark, Marie
Wang, Fang
Bodet, Nancy D.
Kim, Brian S.
author_facet Clark, Marie
Wang, Fang
Bodet, Nancy D.
Kim, Brian S.
author_sort Clark, Marie
collection PubMed
description
format Online
Article
Text
id pubmed-7178825
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71788252020-04-24 Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial Clark, Marie Wang, Fang Bodet, Nancy D. Kim, Brian S. Health Sci Rep Research Letter John Wiley and Sons Inc. 2020-04-23 /pmc/articles/PMC7178825/ /pubmed/32337373 http://dx.doi.org/10.1002/hsr2.154 Text en © 2020 The Authors. Health Science Reports published by Wiley Periodicals LLC This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Letter
Clark, Marie
Wang, Fang
Bodet, Nancy D.
Kim, Brian S.
Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial
title Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial
title_full Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial
title_fullStr Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial
title_full_unstemmed Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial
title_short Evaluation of apremilast in chronic pruritus of unknown origin: A proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial
title_sort evaluation of apremilast in chronic pruritus of unknown origin: a proof‐of‐concept, phase 2a, open‐label, single‐arm clinical trial
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178825/
https://www.ncbi.nlm.nih.gov/pubmed/32337373
http://dx.doi.org/10.1002/hsr2.154
work_keys_str_mv AT clarkmarie evaluationofapremilastinchronicpruritusofunknownoriginaproofofconceptphase2aopenlabelsinglearmclinicaltrial
AT wangfang evaluationofapremilastinchronicpruritusofunknownoriginaproofofconceptphase2aopenlabelsinglearmclinicaltrial
AT bodetnancyd evaluationofapremilastinchronicpruritusofunknownoriginaproofofconceptphase2aopenlabelsinglearmclinicaltrial
AT kimbrians evaluationofapremilastinchronicpruritusofunknownoriginaproofofconceptphase2aopenlabelsinglearmclinicaltrial